|
|||||
|
|
Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection |
|
| Authors: | Janaki Amin Mark A. Boyd Nagalingeswaran Kumarasamy Cecilia L. Moore Marcello H. Losso Chidi A. Nwizu Lerato Mohapi Stephen J. Kerr Annette H. Sohn Hedy Teppler Boris Renjifo Jean-Michel Molina Sean Emery David A. Cooper |
| Abstract: | |
| Keywords: | |